BERLI JUCKER PUBLIC COMPANY LIMITED AND RUBIA INVESTMENT LIMITED, A SUBSIDIARY ANNOUNCE THE DISPOSAL OF SHAREHOLDING IN A JOINT VENTURE, THAI KLINIPRO COMPANY LIMITED Berli Jucker would like to announce the sale of its and subsidiary's shares in a joint venture, Thai Klinipro Company Limited, a manufacturer of single use surgical and protective gowns. The details are as follows: 1. The date on which the transaction occurred : 10 October 2001 2. The parties involved: Name Relationship with the company Buyer: Molnlycke Health Care AB A joint venture and a shareholder SE-402, 52 Gothenburg, of Thai Klinipro holding 49,000 Sweden shares equal to 24.50% of total shares Sellers: Berli Jucker Public Company Limited 99 Soi Rubia, Sukhumvit 42 Road Khet Klongtoey, Bangkok Rubia Investments Limited A subsidiary of Berli Jucker P.O.Box 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin Islands 3. The general characteristics of the transaction : Disposal of assets 4. The details of assets involved: Securities -The company name : Thai Klinipro Company Limited -The nature of business : Manufacturer of single use surgical and protective gowns -Registered capital : Baht 200,000,000 divided into 200,000 shares at Baht 1,000 each -Paid-up capital : Baht 200,000,000 -Number of securities disposed of : 151,000 shares -Selling price per share : Baht 2,059.82384 -Proportion of securities holding before : Berli Jucker Public Company Limited 25.4995% Rubia Investments Limited 50.0005% -Proportion of securities holding after : Berli Jucker Public Company Limited None Rubia Investments Limited None 5. The total value of the consideration : Baht 311,033,400 Page 2 6. The value of the assets disposed of : Baht 146,725,000 7. The details of connected persons and of related persons: -Connected persons: % shares Name Position in the company held Mr. David John Nicol President & CEO, Berli Jucker None Director, Rubia Investments None Mr. Steven Alan Weissman Executive Director, Berli Jucker None Director, Rubia Investments None Mr. Karn Chitaravimol Executive Director, Berli Jucker None Director, Rubia Investments None Mr. Augie Palisoc Jr. Executive Director, Berli Jucker None Director, Rubia Investments None Mr. Prasert Maekwatana Executive Director, Berli Jucker 0.0001% Director, Rubia Investments None Mr. Phornchai Athikhomkulchai Executive Director, Berli Jucker 0.0019% Director, Rubia Investments None -Related persons None 8. The nature and extent of the interest of the : Thai Klinipro, a joint venture, connected persons in the transaction manufactures single use surgical and protective gowns for export to Europe. Molnlycke Health Care AB, a shareholder, solely proceeds the management and thoroughly transfers the technical know-how in production. After Berli Jucker determined it as a non-strategic Business for divestment, Molnlycke Health Care AB offered to acquire it from Berli Jucker in order to allow continuity of direction and employment for its staff. 9. The basis used to determine the value of : The value of the transaction was consideration determined on an arms length sales through negotiations between both parties based on economic conditions and the future business prospects for Thai Klinipro. Thai Klinipro is a non-core operation of Berli Jucker; the company believes that the consideration is fair to both Berli Jucker and the Buyer. 10. The reason for the disposal of the assets : Rationalizing business activities by disposing of non-core business of the company. Page 3 11. The proposed utilization of the proceeds : Using as general working capital received 12. The value of the transaction is equal to: =1.14% Based on the net asset value of the assets disposed of/net assets of BJC Group =3.69% Based on the net profit of the assets disposed of/net profit of BJC Group =2.43% Based on the value of the consideration/net assets of BJC Group This is not classified as any transaction class under the SET's notification concerning Rules, Procedures and Disclosure of Acquisition and Disposition of Assets of a Listed Company. ................................. David John Nicol President & Chief Executive Officer 10 October 2001